Research finds cancer risk remains after hormone therapy

A Women's Health Initiative study showed that almost all benefits of hormone therapy for menopause disappeared after therapy ended, but a slightly elevated risk of breast and other cancers persisted for at least three years. The study's investigators cautioned against alarm over the findings, saying that the increased risk for cancer was fairly small.

View Full Article in:

ClipSyndicate · NYTimes.com · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA